Rectal 5‐ASA vs oral 5‐ASA
Symptomatic remission · Patients with quiescent ulcerative colitis
Rectal 5‐ASA showed no clear difference in symptomatic remission compared with oral 5‐ASA (low certainty).
1 finding from 1 review
- Rectal 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis 2012 · Cochrane Headline outcomes onlyRR 1.24 [0.92, 1.66]2 studies · 69 participantsLow